{"created_at":"Sat Feb 01 16:04:17 +0000 2014","id":429646394974932992,"id_str":"429646394974932992","text":"$ABBV to FDA w ORAL HCV combo. Clash With Gilead(ABBV, ENTA, GILD): http:\/\/t.co\/g45Z6gUYvQ ABBV-advantage w lower pricing, same efficacy.","source":"\u003ca href=\"http:\/\/twitter.com\/tweetbutton\" rel=\"nofollow\"\u003eTweet Button\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1166764590,"id_str":"1166764590","name":"Bo Czernyk","screen_name":"MDsearchlight","location":"Sarasota,FL","url":"http:\/\/linkedin.com\/in\/bosearchlight","description":"Executive search in Healthcare, Lifesciences & Finance. Advocate for hepC treatment & patient care policy.","protected":false,"followers_count":203,"friends_count":341,"listed_count":8,"created_at":"Sun Feb 10 19:22:49 +0000 2013","favourites_count":76,"utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":1431,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000716561710\/e2a1210be0c61c2409928c560e95ecb3_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000716561710\/e2a1210be0c61c2409928c560e95ecb3_normal.png","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"ABBV","indices":[0,5]}],"urls":[{"url":"http:\/\/t.co\/g45Z6gUYvQ","expanded_url":"http:\/\/www.fool.com\/investing\/general\/2014\/01\/31\/abbvie-headed-to-fda-clash-with-gilead-set.aspx#.Uu0aMG2ZWPA.twitter","display_url":"fool.com\/investing\/gene\u2026","indices":[68,90]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
